Triple

T4221590
Position Surface form Disambiguated ID Type / Status
Subject Cambridge life sciences ecosystem E94351 entity
Predicate hasKeyCompany P51457 FINISHED
Object Cambridge Epigenetix
Cambridge Epigenetix is a biotechnology company specializing in epigenetic sequencing technologies that enable more detailed and cost-effective analysis of DNA modifications for research and clinical applications.
E422483 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Cambridge Epigenetix | Statement: [Cambridge life sciences ecosystem, hasKeyCompany, Cambridge Epigenetix]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Cambridge Epigenetix
Context triple: [Cambridge life sciences ecosystem, hasKeyCompany, Cambridge Epigenetix]
  • A. Pacific Biosciences
    Pacific Biosciences is a biotechnology company specializing in advanced DNA sequencing technologies, particularly long-read sequencing platforms used in genomics research.
  • B. Insitro
    Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
  • C. Illumina
    Illumina is a biotechnology company best known for developing and manufacturing advanced DNA sequencing and array-based technologies used in genomics research and clinical applications.
  • D. Yale Center for Genomic Health
    The Yale Center for Genomic Health is a research and clinical center at Yale focused on advancing precision medicine through genomic analysis, interpretation, and integration into patient care.
  • E. Eurofins Scientific
    Eurofins Scientific is a global leader in bioanalytical testing services, specializing in food, environmental, pharmaceutical, and clinical laboratory analysis.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Cambridge Epigenetix
Triple: [Cambridge life sciences ecosystem, hasKeyCompany, Cambridge Epigenetix]
Generated description
Cambridge Epigenetix is a biotechnology company specializing in epigenetic sequencing technologies that enable more detailed and cost-effective analysis of DNA modifications for research and clinical applications.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Cambridge Epigenetix
Target entity description: Cambridge Epigenetix is a biotechnology company specializing in epigenetic sequencing technologies that enable more detailed and cost-effective analysis of DNA modifications for research and clinical applications.
  • A. Pacific Biosciences
    Pacific Biosciences is a biotechnology company specializing in advanced DNA sequencing technologies, particularly long-read sequencing platforms used in genomics research.
  • B. Insitro
    Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
  • C. Illumina
    Illumina is a biotechnology company best known for developing and manufacturing advanced DNA sequencing and array-based technologies used in genomics research and clinical applications.
  • D. Yale Center for Genomic Health
    The Yale Center for Genomic Health is a research and clinical center at Yale focused on advancing precision medicine through genomic analysis, interpretation, and integration into patient care.
  • E. Eurofins Scientific
    Eurofins Scientific is a global leader in bioanalytical testing services, specializing in food, environmental, pharmaceutical, and clinical laboratory analysis.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69b3451997e08190851db4a9a588837d completed March 12, 2026, 10:58 p.m.
NER Named-entity recognition batch_69b34f7d20b48190a404638c68c31026 completed March 12, 2026, 11:42 p.m.
NED1 Entity disambiguation (via context triple) batch_69b59642720c81908e68a56b3d30eef9 completed March 14, 2026, 5:09 p.m.
NEDg Description generation batch_69b596cb73ac81909f83daca406ad8c4 completed March 14, 2026, 5:11 p.m.
NED2 Entity disambiguation (via description) batch_69b59a9c386081909c21ad554d403bfc completed March 14, 2026, 5:27 p.m.
Created at: March 12, 2026, 11:04 p.m.